ARM Innovation Hub
Advertisement: Wild Knight Vodka
Mid banner advertisement: BDO
Advertisement: EBCam mid banner
RealVNC mid-banner general
Advertisement EY mid banner
RealVNC mid banner careers
Advertisement: Simpsons Creative
Barr Ellison Solicitors – commercial property
Advertisement: TTP
Advertisement: RSM
Advertisement: Mogrify
Advertisement: Cambridge Network
5 July, 2019 - 12:15 By Kate Sweeney

Oval Medical maintains momentum at Cambridge Research Park

Cambridge Pharma Ltd has joined sister business Oval Medical Technologies Ltd – both part of the SMC Ltd group of companies – on the fast growing Enterprise Zone of Cambridge Research Park. 

Cambridge Pharma Ltd will provide pharmaceutical services to both Oval and to third parties. Oval designs, develops and industrialises patient-centric autoinjectors .  

This latest deal follows lettings to Oval Medical Technologies, Applied Medical Technologies and TeraView who occupy a total of 41,445 sq ft, meaning 55 per cent of the scheme is now let.

Rupert Dando, surveyor in the business space team at Savills Cambridge, told Business Weekly: “Royal London’s Enterprise scheme, which was developed in partnership with XLB, provides premium and flexible mid-tech accommodation ideal for the thriving Cambridge R & D sector. 

“Consequently, Enterprise has attracted a range of occupiers drawn away from the traditional northern cluster due to its competitive rents, R & D capabilities and Enterprise Zone benefits. 

“What’s more, the potential to incorporate bespoke innovative fit-outs has seen businesses who would usually occupy office space, consider these multi-functional buildings. There are now only five units remaining ranging in size from 6,000 sq ft to 14,000 sq ft.”

Cambridge Pharma Ltd was advised by Carter Jonas.

Newsletter Subscription

Stay informed of the latest news and features